FdaApplication
ANDA 211706
Identifiers
- fda_app_no: ANDA211706
Properties
| Property | Value |
|---|---|
| applicant_name | NASPRESS PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2025-05-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MOMETASONE FUROATE | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED;NASAL |
1 product